18
Views
3
CrossRef citations to date
0
Altmetric
Articles

Effect of carni Q-gel (ubiquinol and carnitine) on cytokines in patients with heart failure in the Tishcon study

, , , , , , , & show all
Pages 349-354 | Received 30 Aug 2006, Accepted 22 May 2007, Published online: 23 May 2017

References

  • Anker SD, von Hachling S. Inflammatory mediators in chronic heart failure.: an overview. Heart 2004, 90: 464–70.
  • Mann DL. Inflammatory mediators and the failing heart: past, present and the foreseeable future. Circ Res 2002, 91: 988–98.
  • von Hachling S, Jankowska EA, Anker SD. Tumour necro-sis factor alpha and the failing heart: pathophysiology and therapeutic implications. Basic Res Cardiol 2004, 99: 18–28.
  • Bolger AR Anker SD. Tumor necrosis factor in chronic heart failure: a peripheral view on pathogenesis, clinical manifes-tations and therapeutic implications. Drugs 2000, 60: 1245–57.
  • Silver MA, Langsjoen PH, Szabo S, Patil H, Zelinger A. Effect of atorvastatin on left ventricular diastolic function and ability of coenzyme Q10 to reverse that dysfunction. Am J Cardiol 2004, 94: 1306–10.
  • Singh RB, Pella D, Neki NS, Chandel JP, Rastogi S, Mori H, Otsuka K, Gupta P. Mechanisms of acute myocardial infarction study (MAMIS). Biomed Pharmacother 2004, 58 (Suppl 1): 5111–5.
  • Singh RB, Pella D, Sharma JP, Rastogi S, Kartikey K, Goel VK, Sharma R, Neki NS, Kumar A, Otsuka K. Increased concentrations of lipoprotein(a), circadian rhythms and metabolic reactions, evoked by acute myocardial infarctions, associated with acute reactions, in relation to large break-fasts. Biomed Pharmacother 2004, 58 (Suppl 1): S116–22.
  • Sinatra ST, Sinatra J. L-carnitine and the heart. Keats Pub-lishing, NTC Contemporary Publishing Group, Chicago, 1999, p. 7-35.
  • Rauchhaus M, Coats AJ, Anker SD. The endotoxin-lipopro-tein hypothesis. Lancet 2000; 356: 930–3.
  • Levine B, Kalman J, Mayer J. Elevated circulating levels of tumor necrosis factor alpha in severe chronic heart failure. N Engl J Med 1990; 323: 236–41.
  • Bhagvan HN, Chopra RK. Potential role of ubiquinone (coenzyme Q10) in pediatric cardiomyopathy. Clin Nutr 2005; 24: 331–8.
  • Singh RB, Niaz MA, Agarwal P, Beegum R, Rastogi SS, Sachan DS. A randomised, double-blind, placebo-controlled trial of L-camitine in suspected acute myocardial infarction. Postgrad Med J 1996; 72: 45–50.
  • Esterbaur H, Cheeseman K. Determination of aldehyde per-oxidation products malonaldehyde and 4-hydroxynonenal. Methods Enzymol 1990; 186: 407–21.
  • Niato C. Kawamura M, Yamamoto Y Lipid peroxides as the initiating factor of atherosclerosis. NY Acad Sci 1993; 676: 27–45.
  • Chopra RK, Goldman R, Sinatra ST, Bhagavan HN. Rela-tive bioavailability of coenzyme Q formulations in human subjects. Int J Vit Nutr Res 1998; 68: 109–13.
  • Edlund PO. Determination of coenzyme Q, alpha-toco-pherol and cholesterol in biological samples by coupled-col-umn liquid chromatography with colorimetric and ultravio-let detection. J Chromatogr 1988; 425: 87–97.
  • Littarru GP, Ho L, Folkers K. Deficiency of coenzyme Q10 in human heart disease. II. Int J Vit Nutr Res 1972; 42: 291–5.
  • Folkers K, Littarru GP, Ho L, Runje TM, Havacoda S, Coo-ley D. Evidence for a deficiency of coenzyme Q10 in human heart disease. Int J Vit Res 1970; 40: 380–90.
  • Folkers K, Baker L, Richardson PC, Shizukuishi S, Taka-mura K, Drzewo ski J, Lewandowski J, Ellis JM. Biomed-ical and clinical aspects of coenzyme Q, Vol. 2, Eds. Yama-mura Y, Folkers K, Ito Y, Elsevier, Amsterdam, 1980; p. 449.
  • Mortensen SA. Perspectives on therapy of cardiovascular diseases with coenzyme Q10 (ubiquinone). Clin Invest 1993, 71 (8 Suppl): S116–23.
  • Berman M, Erman A, Ben-Gal T, Dvir D, Georghiou GP, Stamler A, Vered Y, Vidne VA, Aravot D. Coenzyme Q10 in patients with end-stage heart failure awaiting cardiac trans-plantation: a randomized, placebo-controlled study. Clin Cardiol 2004; 27: 295–9.
  • Hughes K, Lee BL, Feng X, Lee J, Ong CN. Coenzyme Q10 and differences in coronary heart disease risk in Asian Indi-ans and Chinese. Free Rad Biol Med 2002; 32: 132–8.
  • Haeckel R, Raiser E, Oellerich M, Siliprandi N. Carnitine metabolism, function and implication. J Clin Chem Clin Metab 1990; 28: 291–5.
  • Wahlqvist ML, Wattanapenpaiboon N, Savige GS, Kannar D. Bioavailability of two different formulations of coen-zyme Q10 in healthy subjects. Asia Pac J Clin Nutr 1998; 7: 37–40.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.